Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease
Alimentary Pharmacology & Therapeutics · 2026-06 · 63 (12) · 1703-1704
DOI: 10.1111/apt.70700 ↗Kurz gefasst
Leserbrief in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 25.04.2026. Verfasst von Jiacheng Li. Beteiligte Einrichtung: Department of Anorectal Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Anorectal Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China.
ORCID-Profile: Jiacheng Li
Zitieren
APA
Li, J. (2026). Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease. Alimentary Pharmacology & Therapeutics, 63(12), 1703-1704. https://doi.org/10.1111/apt.70700
Vancouver
Li J. Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease. Alimentary Pharmacology & Therapeutics. 2026;63(12):1703-1704. doi:10.1111/apt.70700
BibTeX
@article{Li2026,
author = {Li, Jiacheng},
title = {Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {63},
number = {12},
pages = {1703--1704},
doi = {10.1111/apt.70700}
}
EUVIMED